3RX-18227-75836
4 vaccinations
2 coded responses
40 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 770 / TX
- Registered
- 2021-01-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-02
Registered in v-safe
-
2021-01-02
Dose 1 — Pfizer-BioNTech
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-16
-
2021-01-21
Dose 2 — Pfizer-BioNTech
- 2021-01-21
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-04-22
- 2021-07-22
-
2021-09-21
Dose 3 — Pfizer-BioNTech
- 2021-09-29
- 2021-10-05
- 2021-10-12
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-12-21
-
2022-03-22
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID in Jan. 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-09-07
Dose 4 — Pfizer-BioNTech
- 2022-09-21
- 2022-09-23
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-12-07
-
2023-03-08
Survey response — 6 months, dose 4MedDRA: Fatigue, Influenza like illness, Pain, Pyrexia, Respiratory symptom, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-08
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-09
-
2023-03-09
Callback requested for06:00PM ET
-
2023-03-09
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-02 | Pfizer-BioNTech | |
| 2 | 2021-01-21 | Pfizer-BioNTech | |
| 3 | 2021-09-21 | Pfizer-BioNTech | No |
| 4 | 2022-09-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-03-08 | Successful 2023-03-09 |
Completed over the phone |
Free text
Release 11 — 6 months, dose 3
Symptoms: I had COVID in Jan. 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release